$988.62
al cierre: Nov 12 EDT
$994.00
5.380.54%
Pre-comercialización: 8:48 AM EDT
Comments
Loading...
Orientación y previsiones
Eli Lilly emite una orientación sobre las ganancias por acción y los ingresos futuros, lo que ofrece a los inversores una idea de cuánto espera ganar la empresa en los próximos períodos.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
10/30/2025 | LLY | Eli Lilly | FY | 2025 | $23.00 | $23.70 | $22.68 | $63.00B | $63.50B | $62.26B | |
08/07/2025 | LLY | Eli Lilly | FY | 2025 | $21.75 | $23.00 | $22.01 | $60.00B | $62.00B | $60.23B | |
05/01/2025 | LLY | Eli Lilly | FY | 2025 | $20.78 | $22.28 | $22.40 | $58.00B | $61.00B | $59.57B | |
02/06/2025 | LLY | Eli Lilly | FY | 2025 | $22.50 | $24.00 | $22.69 | $58.00B | $61.00B | $58.91B | |
01/14/2025 | LLY | Eli Lilly | FY | 2025 | — | — | — | $58.00B | $61.00B | $58.48B | |
01/14/2025 | LLY | Eli Lilly | FY | 2024 | — | — | — | $45.00B | $45.00B | $45.55B | |
01/14/2025 | LLY | Eli Lilly | Q4 | 2024 | — | — | — | $13.50B | $13.50B | $13.95B | |
10/30/2024 | LLY | Eli Lilly | FY | 2024 | $13.02 | $13.52 | $13.47 | $45.40B | $46.00B | $46.24B | |
08/08/2024 | LLY | Eli Lilly | FY | 2024 | $16.10 | $16.60 | $13.76 | $45.40B | $46.60B | $43.01B | |
04/30/2024 | LLY | Eli Lilly and Co | FY | 2024 | $13.50 | $14.00 | $12.50 | $42.40B | $43.60B | $41.44B | |
02/06/2024 | LLY | Eli Lilly | FY | 2024 | $12.20 | $12.70 | $12.43 | $40.40B | $41.60B | $39.38B | |
11/02/2023 | LLY | Eli Lilly | FY | 2023 | $6.50 | $6.70 | $6.72 | $33.40B | $33.90B | $33.52B | |
08/08/2023 | LLY | Eli Lilly | FY | 2023 | $9.70 | $9.90 | $8.71 | $33.40B | $33.90B | $31.44B | |
04/27/2023 | LLY | Eli Lilly | FY | 2023 | $8.65 | $8.85 | $8.45 | $31.20B | $31.70B | $30.64B | |
02/02/2023 | LLY | Eli Lilly | FY | 2023 | $8.35 | $8.55 | $8.28 | $30.30B | $30.80B | $30.55B | |
01/19/2023 | LLY | Eli Lilly | FY | 2023 | $8.10 | $8.30 | $8.27 | $30.30B | $30.80B | $30.48B | |
12/13/2022 | LLY | Eli Lilly | FY | 2022 | $7.70 | $7.85 | $7.78 | $28.50B | $29.00B | $28.62B | |
12/13/2022 | LLY | Eli Lilly | FY | 2023 | $8.10 | $8.30 | $9.15 | $30.30B | $30.80B | $30.12B | |
11/01/2022 | LLY | Eli Lilly | FY | 2022 | $7.70 | $7.85 | $7.99 | $28.50B | $29.00B | $28.85B | |
08/04/2022 | LLY | Eli Lilly | FY | 2022 | $7.90 | $8.05 | $8.08 | $28.80B | $29.30B | $28.27B | |
04/28/2022 | LLY | Eli Lilly | FY | 2022 | $8.15 | $8.30 | $8.19 | $28.80B | $29.30B | $26.80B | |
02/03/2022 | LLY | Eli Lilly | FY | 2022 | $8.50 | $8.65 | $7.54 | $27.80B | $28.30B | $24.88B | |
12/15/2021 | LLY | Eli Lilly | FY | 2022 | $8.50 | $8.65 | $7.30 | $27.80B | $28.30B | $24.73B | |
12/15/2021 | LLY | Eli Lilly | FY | 2021 | $8.15 | $8.20 | $7.13 | $28.00B | $28.30B | $24.57B |
PREGUNTAS FRECUENTES
¿Cuál es la orientación más reciente de Eli Lilly (LLY)?
La orientación más reciente para Eli Lilly (LLY) se informó el octubre 30, 2025 para el año completo 2025. La empresa proporcionó una guía de ganancias por acción en el rango de $23.00 a $23.70, en comparación con el EPS estimado de $22.68. Además, Eli Lilly pronosticó ingresos entre $63.00B y $63.50B para el trimestre.
Explora orientación y previsión sobre todos los valores.